PEY9 ASSESSMENT OF THE COST-EFFECTIVENESS OF TRAVOPROST VERSUS LATANOPROST, AS SINGLE AGENTS FOR GLAUCOMA TREATMENT IN FRANCE
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63715-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)63715-1/fulltext
Section Title :
Section Order :
568
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63715-1&doi=10.1016/S1098-3015(10)63715-1